Lymphatic Diseases
Showing 1 - 25 of >10,000
Surgical Intervention and Lymphatic Diseases.
Completed
- Lymphedema
- Cancer-related Unilateral
- Normal + Ectasis LVs
-
Kaohsiung, TaiwanKaohsiung Chang Gung Memorial Hospital
Sep 28, 2023
A Prospective Natural History Study of Lymphatic Anomalies
Recruiting
- Lymphatic Diseases
- Lymphatic Abnormalities
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Feb 22, 2023
Lymphatic Diseases, Chylothorax Trial in København Ø (Octreotide Injection, Saline infusion)
Completed
- Lymphatic Diseases
- Chylothorax
- Octreotide Injection
- Saline infusion
-
København Ø, DenmarkRigshospitalet
Jan 4, 2023
Lymphatic Malformations, Lymphatic Diseases Trial in Stanford, Aurora, Chicago (Sildenafil 20 mg tablets, Placebo tablets
Completed
- Lymphatic Malformations
- Lymphatic Diseases
- Sildenafil 20 mg tablets
- Placebo tablets (resembling Revatio)
-
Stanford, California
- +2 more
Oct 25, 2022
Lymphatic Diseases, Hematopoietic Malignancy Trial in Minneapolis (Umbilical Cord Blood (UCB))
Recruiting
- Lymphatic Diseases
- Hematopoietic Malignancy
- Umbilical Cord Blood (UCB)
-
Minneapolis, MinnesotaMasonic Cancer Center, University of Minnesota
Jan 25, 2023
Primary and Secondary Lymphatic Disorders
Recruiting
- Lymphangiomatosis
- +3 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Apr 7, 2022
Lymphoma, Lymphoma, B-Cell, Immune System Diseases Trial in Chapel Hill (iC9-CAR19 T cells, Bendamustine, Fludarabine)
Recruiting
- Lymphoma
- +4 more
- iC9-CAR19 T cells
- +4 more
-
Chapel Hill, North CarolinaLineberger Comprehensive Cancer Center at University of North Ca
Dec 2, 2022
Lymphoma, Lymphoma, Non-Hodgkin, Immune System Diseases Trial in Chapel Hill (ATLCAR.CD30 cells)
Recruiting
- Lymphoma
- +7 more
- ATLCAR.CD30 cells
-
Chapel Hill, North CarolinaLineberger Comprehensive Cancer Center at University of North Ca
Dec 2, 2022
Lymphoma, Adult T-Cell Leukemia/Lymphoma, Lymphatic Diseases Trial in Hollywood, Boston, Chapel Hill (Brentuximab Vedotin, CHEP)
Active, not recruiting
- Lymphoma
- +2 more
- Brentuximab Vedotin
- CHEP
-
Hollywood, Florida
- +3 more
Nov 30, 2022
Lymphoma, Mantle-Cell, Lymphoma, Lymphoproliferative Disorders Trial (Zilovertamab, Ibrutinib, Placebo)
Not yet recruiting
- Lymphoma, Mantle-Cell
- +7 more
- Zilovertamab
- +2 more
- (no location specified)
Jun 21, 2022
Breast Cancer Lymphedema, Secondary Lymphedema, Iatrogenic Lymphedema Trial in Odense (Lymphovenous anastomosis)
Recruiting
- Breast Cancer Lymphedema
- +21 more
- Lymphovenous anastomosis
-
Odense, Region Of Southern Denmark, DenmarkDepartment of Plastic Surgery, Odense University Hospital
Jun 28, 2022
Univentricular Heart, Congenital Heart Disease, Lymphatic Abnormalities Trial in São Paulo (Exercise training)
Completed
- Univentricular Heart
- +5 more
- Exercise training
-
São Paulo, Sao Paulo, BrazilInstituto do Coracao, Faculdade de Medicina da Universidade de S
Jun 28, 2023
Lymphatic Malformation, Generalized Lymphatic Anomaly (GLA), Central Conducting Lymphatic Anomaly Trial in Boston
Recruiting
- Lymphatic Malformation
- +9 more
-
Boston, MassachusettsBoston Children's Hospital
Sep 8, 2022
International Lymphatic Disease and Lymphedema Registry
Recruiting
- Lymphedema
-
Stanford, CaliforniaStanford University School of Medicine
Jul 29, 2021
Immune Cells and Meningeal Lymphatic Drainage in Demyelinating
Recruiting
- Multiple Sclerosis
- +2 more
-
Tianjin, Tianjin, ChinaTianjin Medical University General Hospital
Oct 19, 2022
Lymphatic Diseases Trial in Italy (Brentuximab Vedotin)
Completed
- Lymphatic Diseases
- Brentuximab Vedotin
-
Bologna, Italy
- +3 more
Mar 21, 2022
Diabetes, PAD, Lower Extremity Edema Trial in Houston (Avex Footbeat)
Completed
- Diabetes
- +5 more
- Avex Footbeat
-
Houston, TexasBaylor College of Medicine
Oct 12, 2021
Hodgkin Disease, Lymphoma, Lymphoma, Non-Hodgkin Trial in Chapel Hill, Winston-Salem (ATLCAR.CD30 cells)
Active, not recruiting
- Hodgkin Disease
- +8 more
- ATLCAR.CD30 cells
-
Chapel Hill, North Carolina
- +1 more
Mar 2, 2022
High-grade B-cell Lymphoma, Burkitt Lymphoma, Lymphoma, B-Cell Trial in Busan, Seoul (Sepantronium Bromide)
Not yet recruiting
- High-grade B-cell Lymphoma
- +8 more
- Sepantronium Bromide
-
Busan, Korea, Republic of
- +5 more
Feb 27, 2022
Positron-Emission Tomography Trial in Fuzhou (68Ga-NOTA Evans Blue)
Recruiting
- Positron-Emission Tomography
- 68Ga-NOTA Evans Blue
-
Fuzhou, Fujian, ChinaDepartment of Nuclear Medicine, First Affiliated Hospital of Fuj
Nov 17, 2021
Clearance Mechanisms in Atypical Neurodegenerative Diseases
Not yet recruiting
- Neurodegenerative Diseases
- Frontotemporal Degeneration
-
München, Bayern, GermanyKlinik und Poliklinik für Psychiatrie und Psychotherapie des LMU
Mar 31, 2022
Rheumatoid Arthritis Trial in Rochester (Indocyanine Green, MultiSpectral Imaging System)
Active, not recruiting
- Rheumatoid Arthritis
- Indocyanine Green
- MultiSpectral Imaging System
-
Rochester, New YorkUniversity of Rochester
Jan 20, 2022
Lymphatic Diseases Trial in Italy (Brentuximab Vedotin, Bendamustine)
Terminated
- Lymphatic Diseases
- Brentuximab Vedotin
- Bendamustine
-
Bologna, BO, Italy
- +4 more
May 26, 2021
Rheumatoid Arthritis Trial in Rochester (Indocyanine green, MultiSpectral Imaging System)
Active, not recruiting
- Rheumatoid Arthritis
- Indocyanine green
- MultiSpectral Imaging System
-
Rochester, New YorkUniversity of Rochester
Jan 20, 2022